PATENT CLAIM ANALYSIS

Application Number: 16059072
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "345000"]

Abstract:
The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

Claim (Index 9):
A compound as in  claim 4 , wherein is selected from the group consisting of 8-fluoro-naphth-2-yl and 1-ethyl-4-fluoro-indazol-6-yl; R 1  is hydrogen; R 2  is hydrogen; is selected from the group consisting of \u2014C(ethyl) 2 -, \u2014C(ethyl) 2 -CH 2 \u2014, \u2014CH(isopropyl)-CH 2 \u2014, -(anti)-CH(isopropyl)-CH 2 \u2014, \u2014C(ethyl) 2 -(E)-CH\u2550, \u2014C(ethyl) 2 -(Z)\u2014CH\u2550, \u2014CH(isopropyl)-(E)-CH\u2550, \u2014CH(isopropyl)-(Z)\u2014CH\u2550, and \u2014CH(isopropyl)-C(O)\u2014NH\u2014; wherein the X group is incorporated in the orientation as listed; is selected from the group consisting of pyrrolidin-3-yl-2-one, S-pyrrolidin-3-yl-2-one, piperidin-1-yl-2-one, 1-(methylsulfonyl)-piperidin-4-yl, morpholin-4-yl, tetrahydropyran-4-yl, tetrahydro-thiopyran-4-yl, tetrahydro-thiopyran-4-yl-1,1-dioxide, 1-methyl-benzimidazol-5-yl, oxazol-2-yl, oxazolidin-5-yl-2,4-dione, isoxazol-3-yl and 5-(dimethylamino)-1,3,4-thiadiazol-2-yl; or a tautomer or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.2766
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16059074', '16059075', '13268387', '10502233', '12596685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8316832073031026
- 35 USC 102 Novelty (BERT): 0.6313138934234293
- Combined Prediction Score: 0.8116462759151354
- Mean Citation Score: 464.728304
- Max Citation Score: 621.5414
- Similarity Product: 526.8909436591625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test